ADHD Service Use Patterns in Youth

Ambulatory Pediatrics

Volumn 7, Issue 1 SUPPL., 2007, Pages 107-120

  Leslie, Laurel K ^a   Wolraich, Mark L ^b  

^a CHILD AND ADOLESCENT SERVICES RESEARCH CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

ADHD; attention deficit hyperactivity disorder; education; primary care; service utilization; specialty mental health; stimulants

Indexed keywords

CENTRAL STIMULANT AGENT; PSYCHOTROPIC AGENT;

ADOLESCENT; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CHILD PSYCHIATRY; COGNITIVE THERAPY; DIAGNOSTIC PROCEDURE; DIET THERAPY; DRUG USE; EDUCATION; ETHNICITY; EVIDENCE BASED MEDICINE; FEEDBACK SYSTEM; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH INSURANCE; HUMAN; MEDICAL RESEARCH; MENTAL HEALTH; MENTAL HEALTH SERVICE; PATIENT COMPLIANCE; PRESCRIPTION; PRIMARY MEDICAL CARE; REVIEW; SCHOOL HEALTH SERVICE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; MALE; MENTAL HEALTH SERVICES; OFFICE VISITS; PRIMARY HEALTH CARE; PSYCHOTROPIC DRUGS; SCHOOL HEALTH SERVICES;

EID: 33846464303     PISSN: 15301567     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ambp.2006.05.002     Document Type: Review

References (102)

1. Green M., Wong M., Atkins D., et al. Diagnosis of Attention-Deficit/Hyperactivity Disorder: Technical Review 3. Agency for Health Care Policy and Research publication 99-0050 (1999), US Department of Health and Human Services, Agency for Health Care Policy and Research, Rockville, Md
2. Biederman J., Newcorn J., and Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. Am J Psychiatry 148 (1991) 564-577
3. Biederman J., Faraone S.V., Milberger S., and Jetton J.G. Is childhood oppositional defiant disorder a precursor to adolescent conduct disorder?. Findings from a four-year follow-up study of children with ADHD. J Am Acad Child Adolesc Psychiatry 35 (1996) 1193-1204
4. Jensen P.S., Martin D., and Cantwell D.P. Comorbidity in ADHD: implications for research, practice, and the DSM-IV. J Am Acad Child Adolesc Psychiatry 36 (1997) 1065-1079
5. Pliszka S.R. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview. J Clin Psychiatry 59 (1998) 50-58
6. Spencer T., Biederman J., and Wilens T. Attention-deficit/hyperactivity disorder and comorbidity. Pediatr Clin North Am 46 (1999) 915-927
7. Fergusson D.M., Lynskey M.T., and Horwood L.J. Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood. J Child Psychol Psychiatry 38 (1997) 633-644
8. Fischer M., Barkley R.A., Fletcher K.E., and Smallish L. The adolescent outcome of hyperactive children: predictors of psychiatric, academic, social, and emotional adjustment. J Am Acad Child Adolesc Psychiatry 32 (1993) 324-332
9. Barbaresi W., Katusic S., Colligan R., et al. How common is attention-deficit/hyperactivity disorder?. Towards resolution of the controversy: results from a population-based study. Acta Paediatr 93 (2004) 55-59
10. Busch B., Biederman J., Cohen L.G., et al. Correlates of ADHD among children in pediatric and psychiatric clinics. Psychiatr Serv 53 (2002) 1103-1111
11. Swensen A.R., Birnbaum H.G., Secnik K., et al. Attention-deficit/hyperactivity disorder: increased costs for patients and their families. J Am Acad Child Adolesc Psychiatry 42 (2003) 1415-1423
12. Jensen P.S., Hinshaw S.P., Swanson J.M., et al. Findings from the NIMH multimodal treatment study of ADHD (MTA): implications and applications for primary care providers. J Dev Behav Pediatr 22 (2001) 60-73
13. MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56 (1999) 1073-1086
14. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of Children With Attention-Deficit/Hyperactivity Disorder. Arch Gen Psychiatry 56 (1999) 1088-1096
15. American Academy of Child and Adolescent Psychiatry. Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 30 (1997) 85-121
16. American Academy of Child and Adolescent Psychiatry. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 41 (2002) 537
17. American Academy of Pediatrics. Clinical practice guidelines: diagnosis and evaluation of children with attention-deficit/hyperactivity disorder. Pediatrics 105 (2000) 1158-1170
18. American Academy of Pediatrics. Subcommittee on Attention- Deficit/Hyperactivity Disorder and Committee on Quality Improvement. Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics 108 (2001) 1033-1044
19. DeBar L.L., Lynch F.L., and Boles M. Healthcare use by children with attention deficit/hyperactivity disorder with and without psychiatric comorbidities. J Behav Health Serv Res 31 (2004) 312-323
20. Brehaut J., Miller A., Raina P., and McGrail K. Childhood behavior disorders and injuries among children and youth: a population-based study. Pediatrics 111 (2003) 262-269
21. Hoare P., and Beattie T. Children with attention deficit hyperactivity disorder and attendance at hospital. Eur J Emerg Med 10 (2003) 98-100
22. Kelleher K., Childs G., and Harman J. Healthcare costs for children with attention-deficit/hyperactivity disorder. Econ Neurosci 3 (2001) 60-63
23. Offord D.R., Boyle M.H., Fleming J.E., et al. Ontario Child Health Study: summary of selected results. Can J Psychiatry 34 (1989) 483-491
24. Szatmari P., Offord D.R., and Boyle M.H. Correlates, associates impairments and patterns of service utilization of children with attention deficit disorder: findings from the Ontario Child Health Study. J Child Psychol Psychiatry 30 (1989) 205-217
25. Chan E., Zhan C., and Homer C.J. Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med 156 (2002) 504-511
26. Guevara J., Lozano P., Wickizer T., et al. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics 108 (2001) 71-78
27. Leibson C.L., Katusic S.K., Barbaresi W.J., et al. Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder. JAMA 285 (2001) 60-66
28. Rappley M.D., Gardiner J.C., Jetton J.R., and Houang R.T. The use of methylphenidate in Michigan. Arch Pediatr Adolesc Med 149 (1995) 675-679
29. Ruel J.M., and Hickey C.P. Are too many children being treated with methylphenidate?. Can J Psychiatry 37 (1992) 570-572
30. Sherman M., and Hertzig M.E. Prescribing practices of Ritalin: the Suffolk County, New York study. In: Greenhill L.L., and Osman B.B. (Eds). Ritalin: Theory and Patient Management (1991), Mary Ann Liebert, New York, NY 187-193
31. Zito J.M., Safer D.J., dosReis S., et al. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder. Arch Pediatr Adolesc Med 153 (1999) 1257-1263
32. Habel L.A., Schaefer C.A., Levine P., et al. Treatment with stimulants among youths in a large California health plan. J Child Adolesc Psychopharmacol 15 (2005) 62-67
33. Wolraich M.L. Attention deficit hyperactivity disorder: the most studied and yet most controversial diagnosis. Ment Retard Dev Disabilities Res Rev 5 (1999) 163-168
34. Anastopoulos A.D., Barkley R.A., and Shelton T.L. Family-based treatment: psychosocial intervention for children and adolescents with ADHD. In: Hibbs E.D., and Jensen P.S. (Eds). Psychosocial Treatments for Child and Adolescent Disorders (1996), American Psychological Association, Washington, DC 267-284
35. Jensen P.S., Hinshaw S.P., Kraemer H.C., et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry 40 (2001) 147-158
36. DuPaul G., and Stoner G. ADHD in the Schools: Assessment and Intervention Strategies (2003), Guilford Press, New York, NY
37. Pelham W.E., Wheeler T., and Chronis A. Empirically supported psychosocial treatments for attention-deficit hyperactivity disorder. J Clin Child Psychol 27 (1998) 190-205
38. Epstein M., Shaywitz S., Shaywitz B., and Woolston J. The boundaries of attention deficit disorder. J Learn Disabil 24 (1991) 78-86
39. Zarin D.A., Suarez A.P., Pincus H.A., et al. Clinical and treatment characteristics of children with attention-deficit/hyperactivity disorder in psychiatric practice. J Am Acad Child Adolesc Psychiatry 37 (1998) 1262-1270
40. Bussing R., Zima B.T., and Belin T.R. Variations in ADHD treatment among special education students. J Am Acad Child Adolesc Psychiatry 37 (1998) 968-976
41. Wasserman R.C., Kelleher K.J., Bocian A., et al. Identification of attentional and hyperactivity problems in primary care: a report from Pediatric Research in Office Settings and the Ambulatory Sentinel Practice Network. Pediatrics 103 (1999) E38
42. Wolraich M.L., Lindgren S., Stromquist A., et al. Stimulant medication use by primary care physicians in the treatment of attention deficit hyperactivity disorder. Pediatrics 86 (1990) 95-101
43. US Department of Justice. A guide to disability rights laws. September 2005. Available at: http://www.usdoj.gov/crt/ada/cguide.htm. Accessed September 10, 2006.
44. US Department of Education. Children with ADD/ADHD-topic brief. ED.gov. March 1999. Available at: http://www.ed.gov/print/policy/speced/leg/idea/brief6.html. Accessed September 10, 2006.
45. Jerome L., Gordon M., and Hustler P. A comparison of American and Canadian teachers' knowledge and attitudes towards attention deficit hyperactivity disorder (ADHD). Can J Psychiatry 39 (1994) 563-567
46. Wolraich M., Bickman L., Lambert W., et al. Intervening to improve communication among parents, teachers, and primary care providers of children with ADHD or at high risk for ADHD. J Attention Disord 9 (2005) 354-368
47. Schlitt J., Ricket K., Montgomery L., and Lear J. State initiatives to support school-based health centers: a national survey. J Adolesc Health 17 (1995) 68-76
48. Hoagwood K., Kelleher K.J., Feil M., and Comer D.M. Treatment services for children with ADHD: a national perspective. J Am Acad Child Adolesc Psychiatry 39 (2000) 198-206
49. Chan E., Hopkins J.R., Perrin J.M., et al. Diagnostic practices for attention deficit hyperactivity disorder: a national survey of primary care physicians. Ambul Pediatr 5 (2005) 201-208
50. Stevens J., Harman J.S., and Kelleher K.J. Ethnic and regional differences in primary care visits for attention-deficit hyperactivity disorder. J Dev Behav Pediatr 25 (2004) 318-325
51. Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Morb Mortal Wkly Rep 54 (2005) 842-847
52. Greenhill L.L. Diagnosing attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 59 suppl 7 (1998) 31-41
53. Elia J., Ambrosini P.J., and Rapoport J.L. Treatment of attention-deficit hyperactivity disorder. N Engl J Med 340 (1999) 780-788
54. Goldman L.S., Genel M., Bezman R.J., and Slanetz P.J. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Council on Scientific Affairs, American Medical Association. JAMA 279 (1998) 1100-1107
55. Gibbs N. The age of Ritalin. Time 152 (1998) 86-96 22
56. Wren A. ADHD: dangers of pill popping. Psychology Today (2005) 38-40
57. National Institutes of Health. Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consensus Statement Online 16 (1998) 1-37. http://consensus.nih.gov/1998/1998AttentionDeficitHyperactivityDisorder1 10html.htm Available at: http://consensus.nih.gov/1998/1998AttentionDeficitHyperactivityDisorder1 10html.htm. Accessed September 10, 2006.
58. American Academy of Child and Adolescent Psychiatry. Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 40 (2001) 1352-1355
59. Zito J.M., Safer D.J., DosReis S., et al. Psychotropic practice patterns for youth: a 10-year perspective. Arch Pediatr Adolesc Med 157 (2003) 17-25
60. Safer D.J., and Krager J.M. A survey of medication treatment for hyperactive/inattentive students. JAMA 260 (1988) 2256-2258
61. Safer D.J., Zito J.M., and Fine E.M. Increased methylphenidate usage for attention deficit disorder in the 1990s. Pediatrics 98 (1996) 1084-1088
62. Olfson M., Gameroff M.J., Marcus S.C., and Jensen P.S. National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry 160 (2003) 1071-1077
63. Angold A., Costello E.J., Farmer E.M.Z., et al. Impaired but undiagnosed. J Am Acad Child Adolesc Psychiatry 38 (1999) 129-137
64. Bauermeister J.J., Canino G., Bravo M., et al. Stimulant and psychosocial treatment of ADHD in Latino/Hispanic children. J Am Acad Child Adolesc Psychiatry 42 (2003) 851-855
65. Bussing R., Zima B.T., Perwien A.R., et al. Children in special education programs: attention deficit hyperactivity disorder, use of services, and unmet needs. Am J Public Health 88 (1998) 880-886
66. Bussing R., Zima B.T., Mason D., et al. Use and persistence of pharmacotherapy for elementary school students with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol 15 (2005) 78-87
67. Cox E.R., Motheral B.R., Henderson R.R., and Mager D. Geographic variation in the prevalence of stimulant medication use among children 5 to 14 years old: results from a commercially insured US sample. Pediatrics 111 (2003) 237-243
68. Leslie L.K., Canino G., Landsverk J., et al. ADHD treatment patterns of youth served in public sectors in San Diego and Puerto Rico. Emotional Behav Dis 13 (2005) 224-236
69. Rowland A.S., Umbach D.M., Stallone L., et al. Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina. Am J Public Health 92 (2002) 231-234
70. Safer D.J., and Malever M. Stimulant treatment in Maryland public schools. Pediatrics 106 (2000) 533-539
71. Stevens J., Harman J.S., and Kelleher K.J. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns. J Child Adolesc Psychopharmacol 15 (2005) 88-96
72. Zito J.M., Safer D.J., Riddle M.A., et al. Prevalence variations in psychotropic treatment of children. J Child Adolesc Psychopharmacol 8 (1998) 99-105
73. Hoagwood K., Jensen P.S., Feil M., et al. Medication management of stimulants in pediatric practice settings: a national perspective. J Dev Behav Pediatr 21 (2000) 322-331
74. Radigan M., Lannon P., Roohan P., and Gesten F. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population. J Child Adolesc Psychopharmacol 15 (2005) 44-56
75. Jensen P.S., Kettle L., Roper M.T., et al. Are stimulants overprescribed? Treatment of ADHD in four US communities. J Am Acad Child Adolesc Psychiatry 38 (1999) 797-804
76. Angold A., Erkanli A., Egger H.L., and Costello E.J. Stimulant treatment for children: a community perspective. J Am Acad Child Adolesc Psychiatry 39 (2000) 975-984
77. Zito J.M., Safer D.J., dosReis S., et al. Methylphenidate patterns among Medicaid youths. Psychopharmacol Bull 33 (1997) 143-147
78. Shatin D., and Drinkard C.R. Ambulatory use of psychotropics by employer-insured children and adolescents in a national managed care organization. Ambul Pediatr 2 (2002) 111-119
79. Horwitz S.M., Leaf P.J., Leventhal J.M., et al. Identification and management of psychosocial and developmental problems in community-based, primary care pediatric practices. Pediatrics 89 (1992) 480-485
80. Achenbach T.M., Bird H.R., Canino G., et al. Epidemiological comparisons of Puerto Rican and US mainland children: parent, teacher, and self-reports. J Am Acad Child Adolesc Psychiatry 29 (1990) 84-93
81. Crijnen A.A.M., Achenbach T.M., and Verhulst F.C. Problems reported by parents of children in multiple cultures: the Child Behavior Checklist syndrome constructs. Am J Psychiatry 156 (1999) 569-574
82. Bussing R., Gary F.A., Mills T.L., and Garvan C.W. Parental explanatory models of ADHD: gender and cultural variations. Soc Psychiatry Psychiatr Epidemiol 38 (2003) 563-575
83. DosReis S., Zito J.M., Safer D.J., et al. Parental perceptions and satisfaction with stimulant medication for attention-deficit hyperactivity disorder. J Dev Behav Pediatr 24 (2003) 155-162
84. Perwien A., Hall J., Swensen A., and Swindle R. Stimulant treatment patterns and compliance in children and adults with newly treated attention-deficit/hyperactivity disorder. J Manag Care Pharm 10 (2004) 122-129
85. Stein B., and Orlando M. ADHD treatment in a behavioral health care carve-out: medications, providers, and service utilization. J Behav Health Serv Res 28 (2001) 30-41
86. Zima B.T., Hurlburt M.S., Knapp P., et al. Quality of publicly-funded outpatient specialty mental health care for common childhood psychiatric disorders in California. J Am Acad Child Adolesc Psychiatry 44 (2005) 130-144
87. Odom S., Brantlinger E., Gersten R., et al. Research in special education: scientific methods and evidence-based practices. Exceptional Children 71 (2005) 137-148
88. Garland A., Hurlburt M.S., and Hawley K.M. Examining psychotherapy processes in a service research contest. Clin Psych Sci Practice 13 (2006) 30-46
89. Weersing V.R., Weisz J.R., and Donenberg G.R. Development of the Therapy Procedures Checklist: a therapist-report measure of technique use in child and adolescent treatment. J Clin Child Adolesc Psychol 31 (2002) 168-180
90. Hogue A., Liddle H., Dauber S., and Samoulis J. Linking session focus to treatment outcome in evidence-based treatments for adolescent substance abuse. Psychother Theory Res Pract Train 41 (2004) 83-96
91. Hogue A., Liddle H., Rowe C., et al. Treatment adherence and differentiation in individual versus family therapy for adolescent substance abuse. J Counseling Psychol 45 (1998) 104-114
92. Markowitz J., Spielman L., Scarvalone P., and Perry S. Psychotherapy adherence of therapists treating HIV-positive patients with depressive symptoms. J Psychother Pract Res 9 (2000) 75-80
93. McLeod B., and Weisz J. The therapy process observational coding system-alliance scale: Measure characteristics and predictions of outcome in usual clinical practice. J Consol Clin Psychol 73 (2005) 323-333
94. Task Force on Promotion and Dissemination of Psychological Procedures Division of Clinical Psychology. Training in and dissemination of empirically-validated psychological treatments: reports and recommendations. Clin Psychol 48 (1995) 3-23
95. Kanouse D.E., and Jacoby I. When does information change practitioners' behavior?. Int J Technol Assess Health Care 4 (1988) 27-33
96. Agency for Health Care Policy and Research. Translating Evidence into Practice: What Do We Know?. What Do We Need? (1997), Agency for Health Care Policy and Research, Washington, DC
97. Agency for Health Care Policy and Research. Translating Evidence Into Practice (1998), Agency for Health Care Policy and Research, Washington, DC
98. National Institute of Mental Health. Blueprint for Change: Research on Child and Adolescent Mental Health (2001), National Institutes of Health, Bethesda, MD
99. US Public Health Service Office of the Surgeon General. Report of the Surgeon General's Conference on Children's Mental Health: A National Action Agenda (2000), US Department of Health and Human Services, Washington, DC
100. Hoagwood K., Burns B.J., Kiser L., et al. Evidence-based practice in child and adolescent mental health services. Psychiatr Serv 52 (2001) 1179-1189
101. Leslie L.K., Weckerly J., Plemmons D., et al. Implementing the American Academy of Pediatrics attention-deficit/hyperactivity disorder diagnostic guidelines in primary care settings. Pediatrics 114 (2004) 129-140
102. Perrin J.M., Fluet C., Kuhlthau K.A., et al. Benefits for employees with children with ADHD: findings from the Collaborative Employee Benefit Study. J Dev Behav Pediatr 26 (2005) 3-8